Apotea (APOTEA) — Working Capital to Net Assets Ratio
Apotea (APOTEA) has a Working Capital to Net Assets ratio of 38.4% as of March 2026. Working capital of Skr361.50 Million (current assets of Skr1.41 Billion minus current liabilities of Skr1.05 Billion) is measured against net assets of Skr940.60 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See APOTEA net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apotea Working Capital to Net Assets (2022–2025)
This chart shows how Apotea's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 38.4%, reflecting working capital of Skr361.50 Million against net assets of Skr940.60 Million SEK. Check APOTEA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Apotea (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apotea from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Apotea (APOTEA) total market value.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 28.7% | Skr247.00 Million | Skr859.90 Million | Skr1.12 Billion | Skr871.50 Million | ▲ +6.6 pp |
| 2024 | 22.1% | Skr140.60 Million | Skr636.00 Million | Skr1.02 Billion | Skr880.80 Million | ▲ +16.3 pp |
| 2023 | 5.8% | Skr24.80 Million | Skr425.00 Million | Skr781.50 Million | Skr756.70 Million | ▲ +4.5 pp |
| 2022 | 1.4% | Skr4.90 Million | Skr355.00 Million | Skr721.30 Million | Skr716.40 Million | — |